Tetrahydropteridines for treatment of neurological disorders

Details Tetrahydropteridines for treatment of neurological disorders Tetrahydropteridines for treatment of neurological disorders

1997-05-16

2000-07-04

Bernhardt, Emily

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514241, 514245, 514248, 514250, 544257, 544258, 544260, 544180, 544194, 544250, 544251, 544346, 544350, A61K 31519, C07D47506, C07D47104, C07D48714

Patent

active

060839481

ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric and neurological disorders are disclosed.

REFERENCES:
patent: 3127402 (1964-03-01), Pachter et al.
patent: 4091219 (1978-05-01), Denzel
patent: 4510141 (1985-04-01), Heckondorn
patent: 4665182 (1987-05-01), Nichol
patent: 4701455 (1987-10-01), Nichol
patent: 5198547 (1993-03-01), Bailey et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton

Affiliated with

Also associated with

Rating

Tetrahydropteridines for treatment of neurological disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydropteridines for treatment of neurological disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropteridines for treatment of neurological disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1486795